labetalol and indacaterol

labetalol has been researched along with indacaterol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
He, X; Hu, B; Li, C; Ma, Y; Wang, J; Wang, Y; Xue, W; Zhang, F; Zhang, T	1

Other Studies

1 other study(ies) available for labetalol and indacaterol

Article	Year
Carvedilol serves as a novel CYP1B1 inhibitor, a systematic drug repurposing approach through structure-based virtual screening and experimental verification. European journal of medicinal chemistry, 2020, May-01, Volume: 193 Topics: A549 Cells; Carvedilol; Cell Proliferation; Cell Survival; Cytochrome P-450 CYP1B1; Density Functional Theory; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Repositioning; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured	2020

Article

Year

Carvedilol serves as a novel CYP1B1 inhibitor, a systematic drug repurposing approach through structure-based virtual screening and experimental verification.

European journal of medicinal chemistry, 2020, May-01, Volume: 193

Topics: A549 Cells; Carvedilol; Cell Proliferation; Cell Survival; Cytochrome P-450 CYP1B1; Density Functional Theory; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Repositioning; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Tumor Cells, Cultured

2020